192 related articles for article (PubMed ID: 21666475)
1. Quantifying HLA-specific antibodies in patients undergoing desensitization.
Zachary A; Reinsmoen NL
Curr Opin Organ Transplant; 2011 Aug; 16(4):410-5. PubMed ID: 21666475
[TBL] [Abstract][Full Text] [Related]
2. The role of the histocompatibility laboratory in desensitization for transplantation.
Leffell MS; Zachary AA
Curr Opin Organ Transplant; 2009 Aug; 14(4):398-402. PubMed ID: 19417655
[TBL] [Abstract][Full Text] [Related]
3. Antiallograft antibodies: relevance, detection, and monitoring.
Leffell MS; Zachary AA
Curr Opin Organ Transplant; 2010 Feb; 15(1):2-7. PubMed ID: 19898236
[TBL] [Abstract][Full Text] [Related]
4. Donor-specific anti-HLA antibody monitoring and removal in solid organ transplant recipients.
Everly MJ
Clin Transpl; 2011; ():319-25. PubMed ID: 22755425
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
6. Summarizing the use of donor specific anti-HLA antibody monitoring in transplant patients.
Everly MJ
Clin Transpl; 2011; ():333-6. PubMed ID: 22755427
[TBL] [Abstract][Full Text] [Related]
7. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.
Reinsmoen NL; Lai CH; Vo A; Cao K; Ong G; Naim M; Wang Q; Jordan SC
Transplantation; 2008 Sep; 86(6):820-5. PubMed ID: 18813107
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
Pavlova YA; Malek I; Honsova E; Netuka I; Sochman J; Lodererova A; Kolesar L; Striz I; Skibova J; Slavcev A
Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation.
Zeevi A; Lunz JG; Shapiro R; Randhawa P; Mazariegos G; Webber S; Girnita A
Hum Immunol; 2009 Aug; 70(8):645-50. PubMed ID: 19527760
[TBL] [Abstract][Full Text] [Related]
10. Current methodologies for detecting sensitization to HLA antigens.
Cecka JM
Curr Opin Organ Transplant; 2011 Aug; 16(4):398-403. PubMed ID: 21666477
[TBL] [Abstract][Full Text] [Related]
11. Defining unacceptable HLA antigens.
Zachary AA; Montgomery RA; Leffell MS
Curr Opin Organ Transplant; 2008 Aug; 13(4):405-10. PubMed ID: 18685337
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S
Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of circulating donor-specific HLA antibodies.
Claas FH
Curr Opin Organ Transplant; 2010 Aug; 15(4):462-6. PubMed ID: 20613523
[TBL] [Abstract][Full Text] [Related]
14. The Most Common HLA Alleles and Anti-HLA Antibodies to Know for Virtual Cross-Match.
Baştürk B; Kantaroğlu B; Kavuzlu M; Sarıtürk Ç
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):53-55. PubMed ID: 27805512
[TBL] [Abstract][Full Text] [Related]
15. Desensitization: achieving immune detente.
Zachary AA; Eng HS
Tissue Antigens; 2011 Jan; 77(1):3-8. PubMed ID: 21155718
[TBL] [Abstract][Full Text] [Related]
16. Alloantibodies and the outcome of cadaver kidney allografts.
Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of highly sensitized patients via the acceptable mismatch program or desensitization? We need both.
Doxiadis II; Claas FH
Curr Opin Organ Transplant; 2009 Aug; 14(4):410-3. PubMed ID: 19417658
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibitor treatment of antibody-mediated allograft rejection.
Woodle ES; Alloway RR; Girnita A
Curr Opin Organ Transplant; 2011 Aug; 16(4):434-8. PubMed ID: 21753709
[TBL] [Abstract][Full Text] [Related]
19. Annual literature review of donor-specific HLA antibodies after organ transplantation.
Kaneku H
Clin Transpl; 2011; ():311-8. PubMed ID: 22755424
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation.
Lee J; Park Y; Kim BS; Lee JG; Kim HJ; Kim YS; Huh KH
Transplant Proc; 2015 Apr; 47(3):649-52. PubMed ID: 25891704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
